Akebia Therapeutics: Q4 Earnings Snapshot
By AP News
Published - Mar 09, 2023, 07:45 AM ET
Last Updated - Jun 22, 2023, 05:12 PM EDT
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $7.6 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 4 cents.
The kidney disease treatment developer posted revenue of $55.2 million in the period.
For the year, the company reported that its loss narrowed to $92.6 million, or 51 cents per share. Revenue was reported as $292.6 million.
